Vascular endothelial growth factor and soluble vascular endothelial growth factor receptor-1 in patients with end-stage renal disease Associations with laboratory findings, comorbidities, and medications

Erturk, Ismail; Yesildal, Fatih; Acar, Ramazan; Ozgurtas, Taner; Saglam, Kenan

doi:10.15537/smj.2018.6.22024

Vascular endothelial growth factor and soluble vascular endothelial growth factor receptor-1 in patients with end-stage renal disease Associations with laboratory findings, comorbidities, and medications

Atıf İçin Kopyala

Erturk I., Yesildal F., Acar R., Ozgurtas T., Saglam K.

SAUDI MEDICAL JOURNAL, cilt.39, ss.586-591, 2018 (SCI İndekslerine Giren Dergi)

Cilt numarası: 39 Konu: 6
Basım Tarihi: 2018
Doi Numarası: 10.15537/smj.2018.6.22024
Dergi Adı: SAUDI MEDICAL JOURNAL
Sayfa Sayıları: ss.586-591

Özet

Objectives: To show the levels of vascular endothelial growth factor (VEGF), soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) in patients with end-stage renal disease (ESRD) and to show the associations with clinical findings such as demographic features, laboratory findings, comorbidities, and medications.